Catheter Related Bloodstream Infection Market to Reach US$ 2.1 Billion by 2023

samruddhicmi123

Catheter Related Bloodstream Infection Market to Reach US$ 2.1 Billion by 2023

The Global Catheter Related Bloodstream Infection Market is estimated to be valued at US$ 2.1 billion in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Catheter-related bloodstream infections (CRBSIs) occur when bacteria or other pathogens enter the bloodstream through a catheter. These infections can be life-threatening and require immediate medical attention. The demand for catheter-related bloodstream infection products is driven by the increasing number of patients requiring catheters for medical procedures, particularly in hospitals and other healthcare settings. These products help in preventing and managing infections, improving patient outcomes, and reducing healthcare costs associated with treating CRBSIs.

Market Key Trends:

One of the key trends in the catheter-related bloodstream infection market is the growing adoption of antimicrobial catheters. Antimicrobial catheters are designed to prevent the attachment and growth of bacteria, thereby reducing the risk of bloodstream infections. These catheters are coated with antimicrobial agents such as silver or chlorhexidine, which have broad-spectrum antimicrobial activity. The use of antimicrobial catheters has shown promising results in reducing the incidence of CRBSIs in various clinical settings. The increasing awareness about the benefits of antimicrobial catheters among healthcare professionals and the growing focus on infection prevention are driving the demand for these products in the market.

Segment Analysis:

The catheter-related bloodstream infection market can be segmented based on catheter type, infection type, end-user, and region. One of the dominating sub-segments in this market is the central venous catheters segment. This is primarily due to the widespread usage of central venous catheters in various medical procedures and the higher incidence of bloodstream infections associated with them. Central venous catheters are commonly used for critical care patients, cancer patients, and patients requiring long-term intravenous therapies. These catheters provide easy access to the bloodstream, but they also pose a higher risk of infection compared to other catheter types. As a result, efforts to prevent and treat catheter-related bloodstream infections have primarily focused on central venous catheters.

Key Takeaways:

The Global Catheter-Related Bloodstream Infection Market is expected to witness high growth, exhibiting a CAGR of 5.1% over the forecast period (2023-2031). This growth can be attributed to several factors. Firstly, the increasing prevalence of chronic diseases that require catheter usage, such as cancer, cardiovascular diseases, and renal diseases, is driving the demand for catheters. Additionally, the rising geriatric population, with an increased susceptibility to infections, further contributes to the market growth.

In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the catheter-related bloodstream infection market. This can be attributed to several factors, including the presence of advanced healthcare infrastructure, high healthcare expenditure, and the overall awareness regarding infection control and prevention. Furthermore, the high prevalence of chronic diseases and the growing adoption of advanced catheters in this region are fueling market growth.

Key players operating in the catheter-related bloodstream infection market include Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, AstraZeneca Pharma India Ltd., Glenmark Pharmaceuticals Ltd., Xellia Pharmaceuticals Ltd., and Pfizer. These companies are focusing on developing innovative catheter technologies, investing in research and development, and collaborating with healthcare institutions to increase their market share and provide effective solutions for catheter-related bloodstream infections.

samruddhicmi123

naufan 2024-03-15

The Global Catheter Related Blood Stream Infection Market is estimated to be valued at US$ 1875. Key Takeaways Key players operating in The Catheter Related Blood Stream Infection Market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co. The geopolitical situation is impacting the growth of the Catheter Related Blood Stream Infection market in multiple ways. The United States currently accounts for the largest share of the global Catheter Related Blood Stream Infection market in terms of value. The Asia Pacific region holds significant growth potential for the Catheter Related Blood Stream Infection market.

Growing Concern Over Catheter Related Blood Stream Infections

naufan003 2024-03-20

Impact on Healthcare Industry Catheter related bloodstream infections (CRBSIs) have been a longtime challenge for hospitals and healthcare facilities. Several studies have found the infection rates to be higher for patients in intensive care units who require central lines for extended periods. Improving Prevention Strategies To combat the growing problem of CRBSIs, healthcare facilities have stepped up prevention efforts through multifaceted strategies. Areas like intensive care units dealing with high-risk patients still report significant infection rates. Get More Insights On Catheter Related Blood Stream Infections

Infection Control Market Size, Market Growth, Scope, And Analysis 2023-2032

Shraddha 2023-07-26

The Business Research Company’s Infection Control Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Infection Control Global Market Report 2023 evaluates infection control market size, growth rate, drivers, trends, and major companies. id=10061&type=smp The global infection control market size is expected to grow from $112. The global infection control market size is expected to reach $15. Africa Infection Control Market27.

Understanding the Complexities of Antibiotic Resistance on a Global Scale: Impacts and Strategies

Leena Shedmake 2024-04-08

However, the rise of antibiotic resistance has become a formidable challenge, threatening to undo decades of progress in combating infectious diseases. In this blog, we'll delve into the complexities of antibiotic resistance on a global scale, examining its impacts and exploring strategies to address this urgent public health threat. Challenges in Addressing Antibiotic ResistanceAddressing antibiotic resistance is a complex and multifaceted challenge that requires coordinated action at the local, national, and global levels. Strategies to Combat Antibiotic ResistanceCombatting antibiotic resistance requires a comprehensive approach that encompasses prevention, surveillance, stewardship, and innovation. Looking Ahead: A Call to ActionAs antibiotic resistance continues to escalate, the need for urgent action has never been greater.

Infection Control Market 2023 - Industry Analysis, Business Opportunity, Development, Growth Factors And Outlook 2032

sai tbrc 2023-06-15

Will Infection Control Market is Really Expected to Reach $38.61 Billion? (Global Share and Growth Factor)

Kanika Gupte 2022-09-14

According to a new report published by Allied Market Research, titled, “Infection Control Market by Product & Service, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2028". Increased use of infection control products such as gloves, masks, gowns, shoe covers, sterilization products, disinfection products and others in hospitals and clinics are expected to show a positive impact on the market. Therefore, an overall positive impact of COVID-19 on the infection control market was observed. Key Study Findings -By product and service, the protective barrier segment held the largest infection control market share in 2020 and is expected to remain dominant throughout the forecast period. Per end user, the Hospitals and Clinics segment held the largest infection control market share in 2020 and is expected to remain dominant throughout the forecast period.

WHO TO FOLLOW